Verseau is the Macrophage Company Transforming Immunotherapy. Founded in 2017, Verseau Therapeutics is backed by investors that include 20/20 HealthCare Partners, 3sbio, Alexandria Venture Investments, Highlight Capital, and Yonghua Capital and is headquartered in Bedford.
FOUNDED:
2017
INDUSTRY:
Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
